Used for: Rheumatoid arthritis and juvenile arthritis (JIA) · Psoriatic arthritis · Plaque psoriasis · Crohn’s disease · Ulcerative colitis · Ankylosing spondylitis (arthritis of the spine) · Hidradenitis suppurativa (painful lumps under the skin) · Non-infectious uveitis (inflammation in the middle or back of the eye) · 7 more
How to pay the least
Ask for the cash price
Yusimry
Yusimry is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
What to do
Ask your pharmacy for Yusimry’s cash price, and one or two other pharmacies too.
Yusimry’s savings card works only with insurance from a job or one you bought.
Compare every option
Brand name
Yusimry, the original
Cash priceAsk the pharmacy
Ways to save on Yusimry
The maker’s card
YUSIMRY Solutions Copay Savings Program
Savings card from Meitheal Pharmaceuticals
No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as$0a dose
The card takes up to $100 a month off your co-pay.
“Pay as little as $0 per dose of YUSIMRY with the YUSIMRY Solutions™ Copay Card…”
From the maker’s offer on patient.yusimry.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Maker’s card or discount card?
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
Authorized generic
There isn’t one.
Not soldThere isn’t one
Regular generic
Yusimry is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
YUSIMRY is a tumor necrosis factor (TNF) blocker indicated for:
Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
Reducing signs and symptoms in adult patients with active ankylosing spondylitis.
Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
Treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
Source: the FDA label for Yusimry (Meitheal Pharmaceuticals Inc.), October 12, 2026. Full label on DailyMed
Good to know
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/yusimry/